Enteric Neurons With Alpha Synuclein Pathology is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Enteric neurons in the gastrointestinal tract accumulate alpha-synuclein (α-syn) pathology in Parkinson's disease and are believed to be among the earliest sites of pathological aggregation, potentially initiating the spread of neurodegeneration to the central nervous system.
- Myenteric Plexus (Auerbach): Controls gut motility
- Submucosal Plexus (Meissner): Regulates secretion
- Neuron Types: Sensory, motor, interneurons
- Cholinergic: Excitatory motor neurons
- Nitrergic: Inhibitory motor neurons
- Sensory: Intrinsic primary afferent neurons (IPANs)
- Interneurons: Local circuit processing
- Enteric Nervous System: Early α-syn accumulation
- Vagus Nerve: Proposed conduit to brain
- Timeline: Pre-diagnostic pathology
- Phosphorylated α-syn: pSer129 positive inclusions
- Lewy neurites: Axonal pathology
- Lewy bodies: Somatic inclusions
- Propagation: Braak staging correlation
- Cholinergic neurons: Particularly vulnerable
- Nitrergic neurons: Also affected
- Sensory neurons: Early involvement
- Native α-syn Misfolding: Conformational change
- Seed Propagation: Templated aggregation
- Oligomer Formation: Toxic intermediates
- Fibril Assembly: Lewy body components
- Long-lived proteins: Limited turnover
- High neuronal activity: Enhanced release
- Mitochondrial stress: ROS production
- Autophagy impairment: Reduced clearance
- Trans-synaptic transfer: Between connected neurons
- Extracellular vesicles: Secreted α-syn
- Tunneling nanotubes: Direct cell-cell transfer
- Vagal transport: To dorsal motor nucleus
- Constipation: Early non-motor symptom
- REM sleep behavior disorder: Associated with ENS pathology
- Olfactory dysfunction: Concomitant pathology
- Rectal biopsy: Detects α-syn pathology
- Colonoscopy samples: Research applications
- Biomarker development: Early detection
- α-syn targeting: Antibodies, vaccines
- Aggregation inhibitors: Small molecules
- Gut-targeted approaches: Local delivery
- Neuroprotective agents: Before CNS spread
- Lifestyle modifications: Diet, exercise
- Gut microbiome modulation: Therapeutic target
The study of Enteric Neurons With Alpha Synuclein Pathology has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] DOI:10.1038/s41586-019-1833-8 - α-Syn in enteric neurons
[2] DOI:10.1002/mds.27817 - Gut-brain axis in PD
[3] DOI:10.1016/j.nbd.2021.105392 - ENS pathology in PD